Company intelligence / Profile preview

InfoBionic.Ai

Chelmsford, Massachusetts, United States

Ownership: Private
Employees: ~35
Development stage: Other

Overview

InfoBionic.Ai's FDA-cleared, AI-enabled MoMe ARC platform provides remote, continuous, near real-time 6-lead ECG quality cardiac arrhythmia detection and has become recognized as a gold standard in remote cardiac care. Clinical adoption includes partnership with leading medical institutions and integration with Epic's Connection Hub, enabling earlier and more accurate arrhythmia and cardiac disease detection in real-world ambulatory settings.[1][2][3][4][5][6]

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Mayo ClinicAnumanaHBox.aiEpic (EHR integration)

Beyond the preview

Go deeper on InfoBionic.Ai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InfoBionic.Ai.

Explore the full profile